Literature DB >> 35291696

Editorial: Multimodality Treatment in Pancreatic Ductal Adenocarcinoma - Current Options and the Future Impact of Molecular Biological Profiling.

Marko Kornmann1, Alexander Kleger2.   

Abstract

Entities:  

Year:  2022        PMID： 35291696      PMCID： PMC8874236          DOI： 10.1159/000521419

Source DB:  PubMed          Journal:  Visc Med        ISSN： 2297-4725


× No keyword cloud information.
  7 in total

1.  Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients.

Authors:  Thilo Hackert; Milena Sachsenmaier; Ulf Hinz; Lutz Schneider; Christoph W Michalski; Christoph Springfeld; Oliver Strobel; Dirk Jäger; Alexis Ulrich; Markus W Büchler
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

2.  Cancer modeling meets human organoid technology.

Authors:  David Tuveson; Hans Clevers
Journal:  Science       Date:  2019-06-07       Impact factor: 47.728

3.  Pancreatic adenocarcinoma.

Authors:  David P Ryan; Theodore S Hong; Nabeel Bardeesy
Journal:  N Engl J Med       Date:  2014-11-27       Impact factor: 91.245

4.  Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.

Authors:  Michael J Pishvaian; Edik M Blais; Jonathan R Brody; Emily Lyons; Patricia DeArbeloa; Andrew Hendifar; Sam Mikhail; Vincent Chung; Vaibhav Sahai; Davendra P S Sohal; Sara Bellakbira; Dzung Thach; Lola Rahib; Subha Madhavan; Lynn M Matrisian; Emanuel F Petricoin
Journal:  Lancet Oncol       Date:  2020-03-02       Impact factor: 41.316

5.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

6.  The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21

Review 7.  Curing pancreatic cancer.

Authors:  Benno Traub; Karl-Heinz Link; Marko Kornmann
Journal:  Semin Cancer Biol       Date:  2021-05-29       Impact factor: 15.707
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.